Interferon alpha-2 (IFN alpha 2) increases lacrimal and salivary function in Sjögren's syndrome patients. Preliminary results of an open pilot trial versus OH-chloroquine.

Source:http://linkedlifedata.com/resource/pubmed/id/8871834

Download in:

View as

General Info

PMID
8871834